For much of 2023 and indeed, early 2024, the central question facing UK AI companies raising Series A was technical credibility. Investors wanted reassurance that the technology worked, that models were defensible, and that infrastructure could scale under pressure. Demonstrably, at the latter end of 2025, that phase has passed.
Today, technical competence is assumed as a baseline. What investors now examine far more closely is commercial readiness. Revenue mechanics, execution discipline, and evidence that early traction can translate into predictable growth increasingly determine whether a Series A will proceed or stall. This shift helps explain why many UK AI companies are struggling to move beyond the seed stage, even as headline venture capital investment begins to recover.
Public UK funding data shows that Seed activity has remained relatively resilient. In 2024, Seed deals accounted for 41.9 per cent of UK equity deals by count, broadly unchanged year-on-year. Over the same period, total equity deal volumes fell by around 15 per cent, with follow-on deals declining more sharply than initial rounds.
Follow-on deals fell by more than 17 per cent year on year, compared with a roughly 12 per cent decline in initial deals. At the same time, UK startups raised $17.3 billion in venture capital in the first three quarters of 2025, signalling a rebound in headline capital flows relative to the post-2022 trough.
Yes – capital has returned, but progression has become all the more selective.
The bottleneck now sits squarely between Seed and Series A, where fundraising momentum breaks down earlier in the process. Many attempts stall during informal screening and never appear as failed rounds. From the outside, this may appear to be a difficult market. In practice, it reflects a higher bar being applied sooner. For AI companies, this tightening has been particularly pronounced.
UK AI startups are increasingly being assessed against US-style Series A expectations. Investors want clear ARR signals, credible customer expansion paths, and evidence that pilots convert into repeatable revenue. These standards are becoming commonplace in the UK, even though companies do not have access to the same depth of risk capital as in the US.
What would be considered a Seed round domestically often carries expectations closer to a US Series A. The margin for error is narrower, and the tolerance for ambiguity is lower. This environment helps explain why relocation to the US is so frequently raised in founder conversations. The US has been deliberate in positioning itself as the global centre of AI, aligning venture markets, talent policy, and commercial infrastructure around rapid scale and early traction. For founders under pressure, moving can begin to feel inevitable.
In some narratives, relocation or waiting for government policies on tax incentives is framed almost as a rescue story, as if a fairy godmother might appear in a pumpkin carriage with a signed terms sheet. In reality, waiting for external salvation rarely changes the underlying challenges, and geography is not usually what decides a Series A outcome.
In many cases, success hinges on how founders show up in investor conversations. Investors are seeking clarity on how revenue is generated, how sales cycles operate, how customers expand, and how the organisation will execute as complexity increases. They are testing whether a company can move from technical promise to commercial repeatability. Not only this, but there is a significant rise in investors scrutinising not only the business model, but the character, resilience and sheer grit of the founders themselves.
Founders are often expected to articulate these mechanics while still building a product, hiring teams, and supporting early customers. The learning curve is steep, and the expectations are unforgiving. For many teams, the bar is too high to clear without help, particularly when commercial leadership has not kept pace with technical progress.
This, in turn, has created a growing gap in the UK AI ecosystem: innovation remains world-class, research depth is strong, and talent density is high. What many companies lack, however, is structured support to translate technical progress into credible commercial narratives that withstand Series A scrutiny. As a result, promising businesses stall not because investors lack interest, but because confidence erodes around execution and scale.
The founders who navigate this transition most successfully tend to make deliberate changes earlier than their peers. They strengthen commercial leadership, pressure-test revenue assumptions, and refine how they present execution readiness before formal fundraising begins. The impact of this work is often immediate: investor discussions become more focused, diligence moves faster, and the same technology is evaluated through a more credible lens.
Crucially, this does not require a retreat into bootstrapping or an urgent move overseas. It requires recognising that the funding environment has changed and responding directly to what investors now prioritise. Much of the public debate has focused on policy responses. Tax incentives, government intervention, and strategic funding all play a role. However, these measures offer limited assistance to founders who are fundraising at present, with more of their immediate challenges being practical, such as how UK AI founders close the gap between technical excellence and commercial readiness quickly enough to meet modern Series A expectations.
The rising demand for commercialisation support reflects this reality. Founders are not failing. The environment has changed faster than many companies have been able to adapt. If the UK wants to retain its AI companies, the solution is not only about capital supply or regulation. It is about equipping founders to succeed in a funding market that now rewards execution clarity as much as innovation.
That work can begin immediately, and for many AI companies, it will determine whether Series A becomes a ceiling or a gateway.
By Jason Mackay, a technology operator specialising in go-to-market strategy, revenue architecture, and commercial execution for growth-stage technology companies. With early experience at Microsoft and later embedded in high-growth technology environments, he has led go-to-market execution, driven market entry and scale, and helped organisations convert strong technical capability into repeatable commercial performance.
At Highland Consulting, he works closely with founders to validate commercial models, sharpen traction narratives, and prepare their businesses for investor scrutiny and sustainable growth.
